Hypertrichosis, Anterior Cervical

A roundup of the week's most newsworthy health industry press releases from PR Newswire, including the FDA approval of Eli Lilly's drug to treat obesity. NEW YORK, Nov. 10, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Continue Reading PR Newswire Weekly Health Press Release Roundup, Nov. 6-10, 2023. Photo provided by quip. FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems "Far too many hurdles continue to prevent people living with obesity from accessing obesity treatments that could lead to significant weight loss," said Mike Mason, executive vice president and president, Lilly Diabetes and Obesity. "Broader access to these medicines is critical, which is why Lilly is committed to working with healthcare, government and industry partners to ensure people who may benefit from Zepbound can access it." 90% of Women aren't prepared for menopause. Knix wants to change that. Conceptualized by Knix Founder and President, Joanna Griffiths, The Invisible Period is an artistic manifesto style campaign created to shine light on perimenopause - the invisible period that more than half the world's population experiences but don't talk about. NYU Langone Health Performs World's First Whole-Eye and Partial Face Transplant The surgery included transplanting the entire left eye and a portion of the face from a single donor, making this the first-ever human whole-eye transplant in medical history and the only successful combined transplant case of its kind. Emory Healthcare collaborates with Andor Health to provide virtual inpatient monitoring using AI technology ThinkAndor® harnesses generative AI to unlock data stored in various systems including ambient listening and real-time visualization -- to detect common safety risks, such as falls, self-harm and elopement. New Hospital Safety Grades from The Leapfrog Group Find Improved Infection Rates Following Major Spike During COVID-19 Pandemic This cycle, nearly 30% of hospitals earned an "A," 24% earned a "B," 39% earned a "C," 7% earned a "D" and less than 1% earned an "F." Utah is the state with the highest percentage of "A" hospitals in the country this fall. St. Joseph's Hospital to Open First Proton Radiation Therapy Center in Tampa Bay Area Proton therapy delivers precise radiation treatments to cancerous tumors, using protons instead of X-rays to better target cancer and reduce the amount of radiation exposure to healthy tissue. As a result, patients report few side effects and have a lower risk of secondary malignancies. quip Launches Custom-Fit Mouth Guards and Whitening Solutions Users will simply take their detailed impressions at home, mail them back, and quip will send the user a custom Night Guard, custom Sports Guard, or Whitening Kit (with custom trays + 14-day treatment), with a protective storage case. Eko Health Announces Large-Scale Deployment of AI Heart Disease Detection Technology The current gold standard to detect heart failure is a blood test (NT-proBNP) that when ordered alone, initiates a long pathway that often fails to achieve early diagnosis and treatment in those who need it most. This novel deployment can potentially improve heart disease outcomes for millions of people in communities across the UK. The Arab International Women's Forum and Pfizer launch 'DEI by Design' report with recommendations on embedding diversity into MENA health "We believe that the recommendations delivered by the 'DEI by Design' series will pave the way for tangible change, ensuring that women at every level of healthcare – from grassroots workers to senior executive leadership – are empowered, recognised, and celebrated for their growing role at the forefront of health innovation, research and discovery," said AIWF President & Founder Dr. Haifa Al Kaylani. On/Go Launches Sniffles™: A First-of-its-Kind Solution to Take Care of Whatever's Got You Sniffling On/Go's Sniffles™ helps users sleep better, reduce fever, get congestion relief, soothe an itchy throat, calm dry and chapped lips, relax, and even boost the immune system with an all-in-one solution of medication, at-home testing, and immediate access to 24/7 expert medical care, anytime anywhere. Aplos Medical Achieves a Major Milestone in GERD Treatment with Omega PF™ The Omega PF™ device heralds a paradigm shift in GERD treatment. Being the first of its kind, the device seamlessly combines a dual-modality treatment; it not only controls reflux but ensures a natural, uncompromised swallowing process for the patient. Designs for Health Launches Innovative Probiotic Toothpaste, PerioBiotic™ Silver Similar to the role of probiotics in the gastrointestinal tract, beneficial oral bacteria may help maintain dental and oral health. Purified silver may support overall oral wellness, CoQ10 may help support gum health, and grape seed extract may help healthy inflammatory support. Read more of the latest health-related releases from PR Newswire and stay caught up on the top press releases by following @PRNhealth on Twitter. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers and freelancers have access to the following free features: Customization: Create a customized newsfeed that will deliver relevant news right to your inbox. Customize the newsfeed by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include with your next story. Subject Matter Experts: Access ProfNet, a database of industry experts to connect with as sources or for quotes in your articles. Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines, for media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at [email protected]. SOURCE PR Newswire

Sniffles™ is a quick and effective fix to diagnose and treat cough, the common cold, flu, RSV, COVID, and other upper respiratory conditions - all from the comfort of home, or on the go. MIAMI, Nov. 8, 2023 /PRNewswire/ -- On/Go™, the leading health technology platform known for award-winning at-home rapid COVID-19 test-to-treat solutions, expanded its offerings today with the launch of Sniffles™, a quick fix for whatever gets you sniffling. Now anyone can easily get diagnosed, treated, and obtain medical solutions for cough, cold, sore throat, headache, flu and a variety of other upper respiratory conditions. On/Go's Sniffles™ helps users sleep better, reduce fever, get congestion relief, soothe an itchy throat, calm dry and chapped lips, relax, and even boost the immune system with an all-in-one solution of medication, at-home testing, and immediate access to 24/7 expert medical care, anytime anywhere. Continue Reading When needed, Sniffles™ also offers 24/7 telehealth services (no health insurance required), seamless integration with CVS MinuteClinic for in-person support, and $75 worth of remedies, medications, and devices – all for only $39.99. No more scrambling to find remedies, rushing to the pharmacy, or looking for a doctor. Sniffles™ is packed with everything needed to feel better faster - wherever you are. At launch, Sniffles™ is available through leading rapid delivery retailers such as DoorDash, Amazon, and Walmart.com and directly through On/Go app and snifflesfix.com. "Over the past few years, Americans have been plagued by a sea of upper respiratory illness while the Flu, RSV, and COVID Tridemic continues to periodically overwhelm the healthcare systems," said Ron Gutman, Co-Founder and CEO of Intrivo and the inventor of On/Go. "With learnings we've accumulated from serving more than 100 million people and years of research and development, we've created the most accessible all-in-one solution to rapidly tackle upper respiratory ailments. Through a combination of trusted essential medications, top-of-the-line devices, and 24/7 telehealth access, we're helping Sniffles™ users get diagnoses and have their symptoms treated rapidly, efficiently, and cost effectively." There are more than a billion cases of colds reported each year in the U.S. and only 10 percent of patients get treatment. Sniffles™ aims to solve the ever recurring cold and flu epidemic that puts a strain on families, doctors, employers, and government by providing a rapid fix that's convenient, easily accessible, and highly effective. "As a father of three, keeping everyone safe and healthy is always top of mind - especially leading into cold and flu season," said Reeve Benaron, Co-Founder and CEO of Intrivo. "I've experienced first hand how time consuming and costly it can be to purchase medicine and remedies for an entire family when sick. It is our hope that Sniffles™ will make its way to homes across the country and provide the care and peace of mind families and individuals need without having to spend hundreds of dollars at the pharmacy. We're extremely pleased with the initial feedback and feel strongly that Sniffles™ will be integral for keeping families healthy this Winter and beyond." Intrivo, On/Go's parent company, is also offering special programs for employers and government agencies to help reduce employee sickness and unnecessary suffering, as well as unplanned PTO, which result in up to $700 savings per employee each year. Employers can calculate their cost savings by using Sniffles™' savings calculator. In fact, 40 percent of all sick days in the U.S. each year (150 million total) are due to the common cold, which results in $25 billion in lost productivity. Additionally, the average consumer will shop for over-the-counter medicine up to 26 times a year, resulting in $338 spent per household on cold and flu remedies. Sniffles™ aims to reduces the risk of spreading illness and the high costs associated with it. To learn more about Sniffles™, visit . About On/Go On/Go is a leading health and technology platform that delivers delightful digital health and care solutions for health and wellness-related conditions such as respiratory care, and weight management. Built on a scalable, extensible platform, On/Go's award-winning digital and physical products harness the power of AI and delightful user experience and design to create solutions that have helped over 100 million people worldwide live healthier, happier lives. About Intrivo Intrivo is a global healthcare technology company committed to delivering highly effective, comprehensive, and delightful population health & care solutions. Its platform features fully integrated, highly scalable, and extensible digital health infrastructure that is engineered to easily connect healthcare partners with speed, quality, and delight. Intrivo is the parent company of On/Go. Media Contact Kylee Kaetzel [email protected] SOURCE Intrivo

I’m a child of the ’60s. Which means I’m a big fan of the Jetsons, everyone’s favorite space-age family. They had flying cars, jetpacks and TV wrist watches. They also had great online healthcare. When little Elroy was sick, a 3D monitor would pop up in the living room and the doctor would appear on the screen. He’d ask Elroy to stick his out his tongue, diagnose his illness, prescribe a medicine and tell him to stay home from school for a day. Well, we’ve reached a point where such futuristic medical care is no longer out of reach. It’s here. Thanks to telehealth and consumer-facing healthcare applications, we now have access to medical care in our own homes. And not a moment too soon. Just look at the numbers. According to the World Health Organization (WHO), the global medical GDP is $8.3 trillion, of which the U.S. spends nearly $4 trillion. This means that here in the U.S. we’ve got a real spending problem when it comes to healthcare. In fact, we spend more than twice as much on healthcare per person as other wealthy nations. Why is our spending so high? One reason is that according to Agency for Healthcare Research and Quality, only five percent of the population accounted for nearly half of healthcare spending in the U.S. These are mostly patients with chronic conditions who are constantly in and out of the hospital. It doesn’t have to be this way. If the medical issues of these patients were properly monitored and cared for, the patients would not have to frequent the hospital. One way to achieve this is to promote self-managed healthcare via telehealth, and self-managed diagnostic home tests for illnesses like influenza, pneumonia, malaria and even Covid-19. This kind of self-testing is not unheard of. For instance, there are more than 400 million people in the world with diabetes. These patients are one of the largest managed-care populations in the world—and they are a real success story, as they measure their own blood glucose levels and inject themselves with the exact right amount of insulin at the exact time they need it, which greatly reduces hospitalizations. Blood glucose monitoring is a good model to use when we look at other areas where we can cut costs and improve outcomes via telehealth. Let’s take heart conditions. Cardiovascular diseases (CVDs) are the leading cause of death globally, claiming nearly 18 million lives each year. What if these patients could use technology to measure and manage their conditions? Now they can. Pairing spectral sensors with lateral flow and digital capabilities makes it possible to create self-administered tests that are easy to read and error-free. Such spectral sensor solutions leverage LED lighting to uncover the qualitative and quantitative composition of a wide variety of materials and substances—and instantly provide relevant and actionable data. These kinds of rapid, accurate and cost-effective testing solutions can be game-changers, since they can help bring a host of medical issues under control. Self-administered lateral flow testing can reduce costs in the system while also saving lives. Let’s look at diabetes again. Self-managed care on the patient end has helped reduce the fatality rate for diabetes patients significantly, since the ’60s and ’70s. Self-testing can be extended across a wide range of conditions. Indeed, better, faster, easier self-testing can be brought to patients with every category of disease. Such widespread early detection will not only save lives but reduce costs. That’s why it’s essential to bring this care to the home via telehealth—to enable earlier detection, earlier intervention, and in the case of diseases like Covid-19, earlier isolation, to limit the spread. To do this, we need the government to promote telehealth and app-based self-testing that does not necessarily require the assistance of a doctor. Online professionals can do the front-end screening and monitoring virtually at a significant cost reduction. This will also promote early intervention and better outcomes. For instance, if a disease like pneumonia is caught in the first 48 hours, the outcome is almost always full recovery. Let’s say you wake up in the morning with a scratchy throat. You do a home test, supervised on a telehealth app to ensure it’s done correctly. The sample is diagnosed for strep, which then alerts your regular doctor or healthcare team that you’ve tested positive. From there, a prescription is written for you and within 24 to 48 hours you are back in action. Better still, self-administered lateral flow technology can give you quantitative results. It can show not only whether you’re sick, but exactly how sick you are. What is the viral load in your body? If your viral load is excessively high, you can be advised to go straight to the hospital. But if it’s low, there are interventions you can do at home to keep it from getting worse. And in the not-too-distant future, you can even be prescribed a personalized dosage of medicine based on your precise viral load. The call to action is that point-of-care testing needs to move to the home and it needs to be supported by a Medicaid or Medicare billing code to support insurance coverage and payment for the testing. Covid-19 should absolutely be a tipping point for this kind of self-testing. Because the way to reduce costs in healthcare is to test early and test often. I, for one, propose that the U.S. government take a leadership position when it comes to self-testing by pushing for billing codes that allow healthcare companies to offer these types of services. The good news is that the technology is already here. We just need insightful political leadership to bring this new healthcare approach to the general population. When we have it, we can reduce costs, and save lives. Now, about getting that jetpack…